abstract |
DIAMINOPHENOTIAZIN COMPOUNDS, DRUG PRODUCT AND COMPOSITION UNDERSTANDING THE SAME, AS WELL AS USES OF THOSE COMPOUNDS The present invention generally relates to methods and materials for use in the treatment or prophylaxis of diseases, for example, cognitive disorders, using diaminophenothiazines. In particular, it releases for treatments having optimized pharmacokinetic properties, and dosage forms are intended to improve the benefits of CNS or related cognitive properties of diaminophenothiazines, for example, compared to hematological effects. |